These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 23291628)
1. Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus. Ouyang H; Shi Y; Liu Z; Feng S; Li L; Su N; Lu Y; Kong S Mol Med Rep; 2013 Mar; 7(3):1031-7. PubMed ID: 23291628 [TBL] [Abstract][Full Text] [Related]
2. [Abnormality and significance of interleukin-9 and CD4(+)interleukin-9(+) T-cells in peripheral blood of patients with systemic lupus erythematosus]. Ouyang H; Shi YB; Su N; Li LY Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):99-103. PubMed ID: 23648344 [TBL] [Abstract][Full Text] [Related]
3. Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus. Ouyang H; Shi YB; Liu ZC; Wang Z; Feng S; Kong SM; Lu Y Am J Med Sci; 2014 Aug; 348(2):156-61. PubMed ID: 25054737 [TBL] [Abstract][Full Text] [Related]
4. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus. Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138 [TBL] [Abstract][Full Text] [Related]
5. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus. Lin J; Yue LH; Chen WQ Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261 [TBL] [Abstract][Full Text] [Related]
6. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [TBL] [Abstract][Full Text] [Related]
7. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258 [TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926 [TBL] [Abstract][Full Text] [Related]
9. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus. Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y; Feng L Exp Biol Med (Maywood); 2013 Feb; 238(2):193-9. PubMed ID: 23576801 [TBL] [Abstract][Full Text] [Related]
10. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064 [TBL] [Abstract][Full Text] [Related]
11. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734 [TBL] [Abstract][Full Text] [Related]
12. E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients. Zhao M; Liu Q; Liang G; Wang L; Luo S; Tang Q; Zhao H; Su Y; Yung S; Chan TM; Lu Q J Autoimmun; 2013 Mar; 41():152-60. PubMed ID: 23340290 [TBL] [Abstract][Full Text] [Related]
13. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells. Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646 [TBL] [Abstract][Full Text] [Related]
14. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides. Dar SA; Das S; Ramachandran VG; Bhattacharya SN; Mustafa MD; Banerjee BD; Verma P J Immunotoxicol; 2012; 9(1):85-95. PubMed ID: 22214240 [TBL] [Abstract][Full Text] [Related]
15. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929 [TBL] [Abstract][Full Text] [Related]
16. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus. Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439 [TBL] [Abstract][Full Text] [Related]
17. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus. Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242 [TBL] [Abstract][Full Text] [Related]
18. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Enghard P; Langnickel D; Riemekasten G Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics. Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730 [TBL] [Abstract][Full Text] [Related]
20. Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus. Yang PT; Kasai H; Zhao LJ; Xiao WG; Tanabe F; Ito M Clin Exp Immunol; 2004 Nov; 138(2):342-7. PubMed ID: 15498047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]